Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials

Background: Swift reversal of oral anticoagulation is deemed essential for the outcome of patients with anticoagulation-related critical bleeding. The aim of this systematic review was to evaluate the benefits and harms of prothrombin complex concentrate (PCC) in patients with oral anticoagulants-re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ovesen, Christian (VerfasserIn) , Purrucker, Jan (VerfasserIn) , Grundtvig, Josefine (VerfasserIn) , Mikkelsen, Theis Bech (VerfasserIn) , Gluud, Christian (VerfasserIn) , Jakobsen, Janus Christian (VerfasserIn) , Christensen, Hanne (VerfasserIn) , Steiner, Thorsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 04 February 2025
In: Scandinavian journal of trauma, resuscitation and emergency medicine
Year: 2025, Jahrgang: 33, Pages: 1-16
ISSN:1757-7241
DOI:10.1186/s13049-025-01334-1
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13049-025-01334-1
Volltext
Verfasserangaben:Christian Ovesen, Jan Purrucker, Josefine Grundtvig, Theis Bech Mikkelsen, Christian Gluud, Janus Christian Jakobsen, Hanne Christensen and Thorsten Steiner

MARC

LEADER 00000naa a2200000 c 4500
001 1932180214
003 DE-627
005 20250731104633.0
007 cr uuu---uuuuu
008 250731s2025 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13049-025-01334-1  |2 doi 
035 |a (DE-627)1932180214 
035 |a (DE-599)KXP1932180214 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ovesen, Christian  |e VerfasserIn  |0 (DE-588)1173836438  |0 (DE-627)1043649565  |0 (DE-576)515739472  |4 aut 
245 1 0 |a Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding  |b a systematic review of randomised clinical trials  |c Christian Ovesen, Jan Purrucker, Josefine Grundtvig, Theis Bech Mikkelsen, Christian Gluud, Janus Christian Jakobsen, Hanne Christensen and Thorsten Steiner 
264 1 |c 04 February 2025 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.07.2025 
520 |a Background: Swift reversal of oral anticoagulation is deemed essential for the outcome of patients with anticoagulation-related critical bleeding. The aim of this systematic review was to evaluate the benefits and harms of prothrombin complex concentrate (PCC) in patients with oral anticoagulants-related critical bleeding. Methods: For this systematic review CENTRAL, MEDLINE, Embase, LILACS, BIOSIS, Web of Science, and clinical trial registries were systematically searched. Clinical study reports were also requested from competent authorities. Eligible for inclusion were randomised clinical trials comparing PCC versus no intervention, placebo, or other reversal interventions in participants with critical bleeding related to ongoing treatment with vitamin K antagonist (VKA) or direct oral anticoagulants (DOAC). Pre-specified primary outcomes were all-cause mortality, health-related quality of life, and serious adverse events for which meta-analyses, Trial Sequential Analysis, and GRADE assessments were conducted. Results: Three trials, randomising a total of 291 participants, evaluated PCC against two different active comparators in participants with VKA-related critical bleeding, and two trials, randomising a total of 534 participants, evaluated PCC against two different active comparators in participants with factor Xa-related critical bleeding. Among participants with VKA-related critical bleeding, meta-analyses showed no evidence of a difference between PCC versus fresh frozen plasma (FFP) when assessing all-cause mortality (risk ratio [RR] 1.05; 95% confidence interval (CI) 0.27 to 4.05; low certainty), health-related quality of life (mean difference 1.04; 95% CI − 0.94 to 3.02; very low certainty), and serious adverse events (RR 1.33; 95% CI 0.94 to 1.88; very low certainty), but information is currently sparse. Among participants with factor Xa-related critical bleeding, PCC could not be shown superior or inferior to other reversal strategies (FFP or andexanet alfa) on any patient-relevant outcome, but information is currently sparse. Conclusion: Among participants with VKA or DOAC-related critical bleeding, evidence from randomised clinical trials is currently insufficient to establish if PCC is superior or inferior versus other interventions in decreasing the risk of undesirable patient-relevant outcomes or improving health-related quality of life. 
650 4 |a Anticoagulants 
650 4 |a Bleeding 
650 4 |a Direct oral anticoagulants 
650 4 |a Prothrombin complex concentrate 
650 4 |a Systematic review 
650 4 |a Vitamin K antagonist 
700 1 |a Purrucker, Jan  |d 1982-  |e VerfasserIn  |0 (DE-588)142755281  |0 (DE-627)638930405  |0 (DE-576)333199219  |4 aut 
700 1 |a Grundtvig, Josefine  |e VerfasserIn  |4 aut 
700 1 |a Mikkelsen, Theis Bech  |e VerfasserIn  |4 aut 
700 1 |a Gluud, Christian  |e VerfasserIn  |4 aut 
700 1 |a Jakobsen, Janus Christian  |e VerfasserIn  |4 aut 
700 1 |a Christensen, Hanne  |e VerfasserIn  |4 aut 
700 1 |a Steiner, Thorsten  |d 1961-  |e VerfasserIn  |0 (DE-588)118107623  |0 (DE-627)079247407  |0 (DE-576)291718779  |4 aut 
773 0 8 |i Enthalten in  |t Scandinavian journal of trauma, resuscitation and emergency medicine  |d London : BioMed Central, 2008  |g 33(2025), Artikel-ID 19, Seite 1-16  |h Online-Ressource  |w (DE-627)582019125  |w (DE-600)2455990-8  |w (DE-576)286921979  |x 1757-7241  |7 nnas  |a Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding a systematic review of randomised clinical trials 
773 1 8 |g volume:33  |g year:2025  |g elocationid:19  |g pages:1-16  |g extent:16  |a Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding a systematic review of randomised clinical trials 
856 4 0 |u https://doi.org/10.1186/s13049-025-01334-1  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250731 
993 |a Article 
994 |a 2025 
998 |g 118107623  |a Steiner, Thorsten  |m 118107623:Steiner, Thorsten  |d 910000  |d 911100  |d 50000  |e 910000PS118107623  |e 911100PS118107623  |e 50000PS118107623  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 8  |y j 
998 |g 142755281  |a Purrucker, Jan  |m 142755281:Purrucker, Jan  |d 910000  |d 911100  |d 50000  |e 910000PP142755281  |e 911100PP142755281  |e 50000PP142755281  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 2 
999 |a KXP-PPN1932180214  |e 4751137123 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1186/s13049-025-01334-1"],"eki":["1932180214"]},"physDesc":[{"extent":"16 S.","noteIll":"Illustrationen"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding","subtitle":"a systematic review of randomised clinical trials","title_sort":"Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding"}],"origin":[{"dateIssuedDisp":"04 February 2025","dateIssuedKey":"2025"}],"relHost":[{"origin":[{"dateIssuedDisp":"2008-","publisher":"BioMed Central","publisherPlace":"London","dateIssuedKey":"2008"}],"id":{"zdb":["2455990-8"],"eki":["582019125"],"issn":["1757-7241"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"SJTREM ; official journal of the Scandinavian Networking Group on Trauma and Emergency Management","title":"Scandinavian journal of trauma, resuscitation and emergency medicine","title_sort":"Scandinavian journal of trauma, resuscitation and emergency medicine"}],"recId":"582019125","titleAlt":[{"title":"SJTREM"}],"disp":"Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding a systematic review of randomised clinical trialsScandinavian journal of trauma, resuscitation and emergency medicine","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Nachgewiesen 16.2008 -"],"note":["Gesehen am 18.08.20"],"part":{"year":"2025","volume":"33","text":"33(2025), Artikel-ID 19, Seite 1-16","pages":"1-16","extent":"16"},"language":["eng"]}],"language":["eng"],"name":{"displayForm":["Christian Ovesen, Jan Purrucker, Josefine Grundtvig, Theis Bech Mikkelsen, Christian Gluud, Janus Christian Jakobsen, Hanne Christensen and Thorsten Steiner"]},"note":["Gesehen am 31.07.2025"],"person":[{"display":"Ovesen, Christian","given":"Christian","role":"aut","family":"Ovesen"},{"given":"Jan","display":"Purrucker, Jan","family":"Purrucker","role":"aut"},{"display":"Grundtvig, Josefine","given":"Josefine","role":"aut","family":"Grundtvig"},{"family":"Mikkelsen","role":"aut","given":"Theis Bech","display":"Mikkelsen, Theis Bech"},{"given":"Christian","display":"Gluud, Christian","family":"Gluud","role":"aut"},{"family":"Jakobsen","role":"aut","given":"Janus Christian","display":"Jakobsen, Janus Christian"},{"display":"Christensen, Hanne","given":"Hanne","family":"Christensen","role":"aut"},{"display":"Steiner, Thorsten","given":"Thorsten","role":"aut","family":"Steiner"}],"recId":"1932180214"} 
SRT |a OVESENCHRIPROTHROMBI0420